Safety and Targeting of Anti-hk2 Antibody in mCRPC
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04116164 |
Recruitment Status : Unknown
Verified October 2020 by Tomopath Inc..
Recruitment status was: Recruiting
First Posted : October 4, 2019
Last Update Posted : April 9, 2021
|
Sponsor:
Tomopath Inc.
Collaborators:
Invicro
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Tomopath Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | December 30, 2021 |
Estimated Study Completion Date : | December 31, 2021 |
Publications: